Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trialHannah Cohen, David Isenberg, Ian Mackie et al.|The Lancet Haematology|2016Cited by 404
161: The Relationship Between Achieved Hemoglobin (HB) & Exercise ToleranceNicola Muirhead, Dennis Churchill, Paul Keown et al.|American Journal of Kidney Diseases|2008Cited by 5